w26052107 gene signature associating with hiv vaccine efficacy and antibody effector function
Published 3 years ago • 1.6K plays • Length 23:37Download video MP4
Download video MP3
Similar videos
-
10:54
w26052102 imbokodo & mosaico updates, plans for correlates and sieve analyses.
-
2:52
w26052100 workshop introduction
-
25:27
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 1/3)
-
56:51
ve-panel 2b: future design approaches for hiv vaccine efficacy trials
-
28:50
s3-04: evaluating an hiv vaccine efficacy vs. counterfactual placebo: immune mediator approach
-
14:40
w26052104 mucosal immune activation in the female genital tract in hvtn702 and rv144 (rv306).
-
34:10
next-generation hiv prevention and therapy: antibody-based approaches
-
13:31
s2-07: vrc01 antibody prevention of hiv
-
1:29:06
webinar 02 – experimental medicine trials for hiv research
-
58:40
ve-panel 2c: research pathway for the use of monoclonal antibodies in hiv prevention.
-
3:11:24
global hiv vaccine enterprise annual stakeholders meeting: accelerating early phase vaccine research
-
1:15:35
challenges and opportunities on the access to future monoclonal antibodies for hiv prevention
-
1:29:48
swinging into full gear: strengthening industry engagement in hiv vaccine research and development
-
57:54
ve panel 1: design approaches for current and future hiv prevention efficacy trials
-
1:20:31
how will covid-19 vaccine development influence future hiv vaccine efforts?
-
19:38
hivr4p // virtual 2021 (sa16) how hiv vaccine r&d is enabling the rapid covid-19 vaccine response
-
1:02:55
ias 2021: official press conference
-
59:12
progress in developing an hiv vaccine: empiricism and a bit of optimism
-
58:25
brown bag lunch: hiv vaccines: research & trends, may 2021